Accendra Health, Inc. ACH
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -3.30% | -0.01% | 3.06% | -40.79% | -58.18% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -3.30% | -0.01% | 3.06% | -40.79% | -58.18% |
| Cost of Revenue | 2.19% | 3.65% | 5.22% | -53.61% | -70.36% |
| Gross Profit | -9.30% | -4.00% | 0.70% | -14.39% | -24.10% |
| SG&A Expenses | -3.23% | -1.15% | -1.21% | -16.03% | -26.07% |
| Depreciation & Amortization | 180.40% | 95.11% | 8.75% | -56.79% | -52.25% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.10% | 2.83% | 2.52% | -42.99% | -60.07% |
| Operating Income | -70.04% | -37.41% | 11.72% | 10.67% | 0.54% |
| Income Before Tax | 70.50% | 64.30% | 69.09% | -5,680.46% | -1,982.83% |
| Income Tax Expenses | -118.25% | -129.62% | -96.50% | 604.79% | 367.63% |
| Earnings from Continuing Operations | 73.56% | 69.12% | 70.72% | -38,900.00% | -4,665.09% |
| Earnings from Discontinued Operations | 75.59% | -3,865.85% | -8,250.43% | -1,819.14% | -2,230.96% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 74.88% | -195.84% | -203.47% | -2,647.63% | -2,734.35% |
| EBIT | -70.04% | -37.41% | 11.72% | 10.67% | 0.54% |
| EBITDA | -36.74% | -29.92% | -21.24% | 2.38% | -4.91% |
| EPS Basic | 74.88% | -196.47% | -203.85% | -2,639.45% | -2,720.93% |
| Normalized Basic EPS | -232.53% | -129.78% | 147.93% | -24.71% | -34.39% |
| EPS Diluted | 74.85% | -196.40% | -203.83% | -2,629.33% | -2,708.97% |
| Normalized Diluted EPS | -233.54% | -129.98% | 152.76% | -23.24% | -33.99% |
| Average Basic Shares Outstanding | -0.44% | -0.29% | 0.29% | 0.73% | 0.96% |
| Average Diluted Shares Outstanding | -0.88% | -0.74% | -0.16% | -0.21% | 0.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |